BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 26547929)

  • 1. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
    Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma.
    Fawzy IO; Hamza MT; Hosny KA; Esmat G; El Tayebi HM; Abdelaziz AI
    FEBS Lett; 2015 Aug; 589(17):2257-65. PubMed ID: 26160756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.
    Zou CD; Zhao WM; Wang XN; Li Q; Huang H; Cheng WP; Jin JF; Zhang H; Wu MJ; Tai S; Zou CX; Gao X
    Oncotarget; 2016 Jan; 7(1):266-78. PubMed ID: 26497556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-591 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Lowering Drug Resistance through Inhibition of Far-Upstream Element-Binding Protein 2-Mediated Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Axis.
    Wang H; Tang Y; Yang D; Zheng L
    Pharmacology; 2019; 104(3-4):173-186. PubMed ID: 31280269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.
    Liu LL; Lu SX; Li M; Li LZ; Fu J; Hu W; Yang YZ; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2014 Jul; 5(13):5113-24. PubMed ID: 24970808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
    Zhou X; Zhang CZ; Lu SX; Chen GG; Li LZ; Liu LL; Yi C; Fu J; Hu W; Wen JM; Yun JP
    Oncogene; 2015 Feb; 34(8):965-77. PubMed ID: 24632613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a.
    Song G; Tian L; Cheng Y; Liu J; Wang K; Li S; Li T
    J Cell Biochem; 2019 Oct; 120(10):18152-18161. PubMed ID: 31190353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z; Xia X; Lu J
    Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-5692a promotes proliferation and inhibits apoptosis by targeting HOXD8 in hepatocellular carcinoma.
    Sun S; Wang N; Sun Z; Wang X; Cui H
    J BUON; 2019; 24(1):178-186. PubMed ID: 30941968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
    Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
    Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1.
    Jiang T; Li M; Li Q; Guo Z; Sun X; Zhang X; Liu Y; Yao W; Xiao P
    Oncol Res; 2017 Aug; 25(7):1117-1127. PubMed ID: 28244848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma.
    Zhou P; Jiang W; Wu L; Chang R; Wu K; Wang Z
    Dig Dis Sci; 2012 May; 57(5):1171-80. PubMed ID: 22373864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
    Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
    BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.